Back to mobile site

Immucell Corp (ICCC) Reports Q4 EPS of $0.01

February 9, 2017 4:37 PM EST

Immucell Corp (NASDAQ: ICCC) reported Q4 EPS of $0.01, versus $0.09 reported last year. Revenue for the quarter came in at $2.2 million, versus $2.7 million reported last year.

For earnings history and earnings-related data on Immucell Corp (ICCC) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings